切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - HDAC - 5-HT7 Receptors - Gap Junctions - Glucagon-like peptide 1 (GLP-1) receptors

11件产品中的 1-10

页面
每页
清除全部
  1. Gap 27
    A1045 Gap 27
     4 Citation
    Target: Gap Junctions
    Summary: 缝隙连接阻断剂
      ≥65.25 mg/mL
      ≥5 mg/mL
  2. Gap 26
    A1044 Gap 26
     8 Citation
    Target: Gap Junctions
    Summary: 间隙连接阻断肽,对应于connexin 43的63-75 aa。
      ≥77.55 mg/mL
      ≥155.1 mg/mL
  3. Chidamide
    B5916 Chidamide
     1 Citation
    Target: HDAC
    Summary: HDAC抑制剂
      ≥18.55 mg/mL
      insoluble in H2O
  4. Exendin-3 (9-39) amide
    B6943 Exendin-3 (9-39) amide
     1 Citation
    Target: Glucagon-like peptide 1 (GLP-1) receptors
    Summary: GLP-1受体拮抗剂
      ≥168.5 mg/mL
      ≥25.2 mg/mL
  5. Lurasidone HCl
    B1477 Lurasidone HCl
    中文名: 盐酸鲁拉西酮
    Target: 5-HT2 Receptors|D2 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺D2/5-HT2A/5-HT7/5-HT1A抑制剂
      ≥11.11 mg/mL
      insoluble in H2O
  6. Quetiapine Fumarate
    B1490 Quetiapine Fumarate
     1 Citation
    中文名: 富马酸奎硫平
    Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺受体拮抗剂
      ≥11.03 mg/mL
      insoluble in H2O
  7. Carbenoxolone disodium
    A8389 Carbenoxolone disodium
     1 Citation
    Target: Gap Junctions
    Summary: 11β-HSD抑制剂
      ≥30.74 mg/mL
      ≥55.1 mg/mL
  8. Vortioxetine
    A3926 Vortioxetine
    中文名: 沃替西汀
    Target: 5-HT1 Receptors|5-HT7 Receptors|5-HT3 Receptors|SERT
    Summary: 5-HT受体拮抗剂
      ≥14.92 mg/mL
      insoluble in H2O
  9. RG2833
    A3761 RG2833
    Target: HDAC
    Summary: 脑渗透性HDAC抑制剂
      ≥16.95 mg/mL
      insoluble in H2O
  10. Exendin-4
    A3408 Exendin-4
    中文名: 艾塞那肽
    Target: Glucagon-like peptide 1 (GLP-1) receptors
    Summary: GLP-1激活剂
      ≥145 mg/mL
      ≥52 mg/mL

11件产品中的 1-10

页面
每页